Clinical Trials

166 enrolled 21 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05364645 2024-07-09

Testing the Use of Targeted Treatment for RET Positive Advanced Non-small Cell Lung Cancer

Phase 2 Withdrawn

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02337530 2024-03-21

Selumetinib in Patients Receiving Pemetrexed and Platinum-based Chemotherapy in Advanced or Metastatic KRAS Wildtype or Unknown Non-Squamous NSCLC

62 enrolled 13 charts

NCT01708993 2023-08-04

Reolysin in Previously Treated Advanced/Metastatic, Non Small Cell Lung Cancer Receiving Standard Salvage Therapy

166 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00101283 2023-07-03

Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural Mesothelioma

Other solid neoplasmThoracic

32 enrolled 8 charts

Mesothelioma, Malignant, Mesothelioma

NCT00053209 2023-06-22

Pemetrexed Disodium and Gemcitabine in Treating Patients With Advanced Cancer of the Urothelium

46 enrolled

Genitourinary

Urinary Bladder Neoplasms, Urethral Neoplasms

NCT02607423 2023-05-25

Fludeoxyglucose F-18 PET/CT in Predicting Response to Chemotherapy in Patients With Stage IIIA Non-small Cell Lung Cancer That Can Be Removed by Surgery

Phase 2 Withdrawn

Other solid neoplasmThoracic

Carcinoma, Non-Small-Cell Lung

NCT02436733 2022-11-07

Pleurectomy/ Decortication (P/D) Preceded or Followed by Chemotherapy in Patients With Early Stage MPM

Phase 2 Unknown

64 enrolled

Mesothelioma, Malignant

NCT02134912 2020-02-20

S1300: Pemetrexed Disodium With or Without Crizotinib in Treating Patients With Stage IV Non-Small Cell Lung Cancer That Has Progressed After Crizotinib

1 enrolled

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung

NCT00096187 2018-04-12

Pemetrexed Disodium in Treating Patients With Recurrent or Persistent Low-Risk Gestational Trophoblastic Tumor After a Molar Pregnancy

55 enrolled

Gestational Trophoblastic Disease

NCT00691301 2018-01-09

Pemetrexed and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer

55 enrolled 10 charts

Uterine Cervical Neoplasms

NCT00087087 2014-02-14

Pemetrexed Disodium in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer

51 enrolled

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT00087100 2014-02-14

Pemetrexed Disodium in Treating Patients With Persistent or Recurrent Endometrial Cancer

51 enrolled

Endometrial Neoplasms

NCT00087113 2014-02-14

Pemetrexed Disodium in Treating Patients With Recurrent Cancer of the Cervix

Uterine Cervical Neoplasms

NCT00265785 2012-11-01

S0526: Pemetrexed Disodium in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

27 enrolled 18 charts

Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00227630 2012-07-18

Pemetrexed Disodium and Cisplatin Followed By Surgery and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma

Other solid neoplasmThoracic

59 enrolled

Mesothelioma, Malignant, Solitary Fibrous Tumor, Pleural

NCT00389688 2012-07-18

Pemetrexed Disodium and Cisplatin Before or After Surgery in Treating Patients With Stage IB or Stage II Non-Small Cell Lung Cancer That Can be Removed by Surgery

13 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00107419 2012-01-18

S0423 Pemetrexed Disodium in Treating Patients With Recurrent and Unresectable or Metastatic Chondrosarcoma